House Subcommittee Chair Seeks Delay Of FDA Foundation Launch
Main Category: Regulatory Affairs / Drug ApprovalsArticle Date: 08 Nov 2007 - 10:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
House Appropriations Subcommittee on Agriculture Chair Rosa DeLauro (D-Conn.) on Thursday in a letter asked FDA officials to delay the launch of the Reagan-Udall Foundation because of concerns about the relationship between the foundation and industries regulated by the agency, CongressDaily reports (Edney, CongressDaily, 11/5).
The foundation, established under a legislation signed into law on Sept. 27, seeks to improve the development of medications and medical devices. On Oct. 3, FDA filed a public notice to seek applications for foundation board members, who must include four industry representatives, three academics, two consumer advocates, one health care provider and four "at-large" members. Some critics have raised concerns because private donations from food, pharmaceutical and medical device companies in large part will fund the foundation (Kaiser Daily Health Policy Report, 10/15).
In the letter, DeLauro raised concerns that the foundation might recommend reduced standards for the safety and effectiveness of products reviewed by FDA without safeguards against the influence of the industries. She wrote, "An independent, effective public-private partnership should be helpful in identifying areas of concern and strategies to benefit patients, consumers and corporations. Unless carefully structured and implemented, the Reagan-Udall Foundation could focus too much on an expedited approval process that results in the sale of blockbuster drugs and devices that are unsafe and ineffective" (CongressDaily, 11/5).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our regulatory affairs / drug approvals section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/88098.php>
APA
http://www.medicalnewstoday.com/releases/88098.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



